Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.
The UK's largest public-private initiative targeting early-stage antimicrobial drug and diagnostic discovery has been introduced by Innovate UK, LifeArc and Medicines Discovery Catapult (MDC). Click to read more.
Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.